Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11655289 Pharmaceutical compositions containing anti-beta amyloid antibodies

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 24 May, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 24 May, 2023
Edits made to:
Infobox (+32 properties)
Article (+338 characters)
‌

 US Patent 11655289 Pharmaceutical compositions containing anti-beta amyloid antibodies

Article

Pharmaceutical compositions containing anti-beta amyloid (Aβ) antibodies or AD-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of Aβ in the central nervous system, mild cognitive impairment, and AD-associated disorders such as Alzheimer's disease.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Biogen
Biogen
0
Current Assignee
Biogen
Biogen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116552890
Date of Patent
May 23, 2023
0
Patent Application Number
166393380
Date Filed
August 22, 2018
0
Patent Citations
‌
US Patent 7666413 Method of reducing viscosity of high concentration protein formulations
0
‌
US Patent 7700751 Humanized antibodies that recognize β-amyloid peptide
0
‌
US Patent 7727957 Treatment and delay of outset of Parkinson's disease
0
‌
US Patent 7763249 Human anti-amyloid β peptide antibody and fragment of said antibody
0
‌
US Patent 7893214 Humanized antibodies that recognize beta amyloid peptide
0
‌
US Patent 7964192 Prevention and treatment of amyloidgenic disease
0
‌
US Patent 8022268 Transgenic animal model for alzheimer's disease
0
‌
US Patent 8034339 Prevention and treatment of amyloidogenic disease
0
‌
US Patent 8128928 Humanized antibodies that recognize beta amyloid peptide
0
‌
US Patent 8263558 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
0
‌
US Patent 8389226 Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
0
‌
US Patent 8703126 Reduced-viscosity concentrated protein formulations
0
‌
US Patent 8753610 Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions
0
‌
US Patent 8906367 Method of providing disease-specific binding molecules and targets
0
‌
US Patent 9670272 Method of providing disease-specific binding molecules and targets
0
‌
US Patent 9828420 Method of providing disease-specific binding molecules and targets
0
‌
US Patent 9910049 Detection of misfolded amyloid beta protein
0
‌
US Patent 10131708 Methods of treating Alzheimer's disease
0
‌
US Patent 10166293 Reduced-viscosity concentrated protein formulations
0
‌
US Patent 10202445 Method of providing disease-specific binding molecules and targets
0
‌
US Patent 10537638 Low concentration antibody formulations
0
‌
US Patent 10842871 Methods for treating Alzheimer's disease
0
‌
US Patent 11008394 High concentration antibody-containing liquid formulation
0
Patent Primary Examiner
‌
Yunsoo Kim
0

Find more entities like US Patent 11655289 Pharmaceutical compositions containing anti-beta amyloid antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo